Roy Kishony
Predicting antibiotic resistance
Technion, Israël Institute of Technology
Prof. Kishony received his B.A. in Physics and Mathematics from the Hebrew University and his Ph.D. in Physics from Tel-Aviv University, after which he moved to Biology as a postdoc at Princeton and Rockefeller Universities. In 2003, he started an independent laboratory at Harvard University, where he became a Full Professor. As a physicist at a major medical school, Prof. Kishony became fascinated by the urgent public health concern over the rapid evolution of antibiotic resistance. His combined theoretical-experimental background enabled him to define key questions in evolution of resistance in bold new ways. His lab has made a series of ground-breaking discoveries, showing how some drug interactions can select against resistance, unraveling mechanisms that keep resistance in check in natural ecological environments, and pioneered unique experimental and theoretical methodologies for tracking whole-genome evolution of pathogenic bacteria. These new approaches and discoveries inspire novel treatment paradigms for effective antimicrobial chemotherapy and genome-based diagnostics. Bringing his expertise in Microbial Evolution, Antibiotic Resistance, and Pathogen Genomics, Prof. Kishony has recently joined the Faculty of Biology at the Technion to develop an interdisciplinary initiative in quantitative biology at the Technion’s Lorry Lokey center for Life Sciences and Engineering. Kishony received the several international awards for his achievements at the intersection of pharmacology, systems biology, and evolution.
Prof. Kishony received his B.A. in Physics and Mathematics from the Hebrew University and his Ph.D. in Physics from Tel-Aviv University, after which he moved to Biology as a postdoc at Princeton and Rockefeller Universities. In 2003, he started an independent laboratory at Harvard University, where he became a Full Professor. As a physicist at a major medical school, Prof. Kishony became fascinated by the urgent public health concern over the rapid evolution of antibiotic resistance. His combined theoretical-experimental background enabled him to define key questions in evolution of resistance in bold new ways. His lab has made a series of ground-breaking discoveries, showing how some drug interactions can select against resistance, unraveling mechanisms that keep resistance in check in natural ecological environments, and pioneered unique experimental and theoretical methodologies for tracking whole-genome evolution of pathogenic bacteria. These new approaches and discoveries inspire novel treatment paradigms for effective antimicrobial chemotherapy and genome-based diagnostics. Bringing his expertise in Microbial Evolution, Antibiotic Resistance, and Pathogen Genomics, Prof. Kishony has recently joined the Faculty of Biology at the Technion to develop an interdisciplinary initiative in quantitative biology at the Technion’s Lorry Lokey center for Life Sciences and Engineering. Kishony received the several international awards for his achievements at the intersection of pharmacology, systems biology, and evolution.